Exhibiting at VIV Asia 2025

Ningbo Sansheng Biological Technology Co., Ltd., headquartered in Ningbo, China, is a globally recognized biotechnology enterprise specializing in the research, production, and export of high-purity animal reproductive hormones and veterinary solutions. With over a decade of expertise in peptide synthesis and hormone biopharmaceuticals, Sansheng plays a crucial role in enhancing fertility management and artificial reproduction technologies in livestock, aquaculture, and veterinary sectors worldwide.

Core Business

Sansheng’s core business revolves around the manufacturing of synthetic reproductive hormones and their formulation into injectable and lyophilized products for veterinary use. The company supports animal breeders and veterinarians with scientifically developed solutions that improve reproduction efficiency and batch management in livestock and aquatic species.

Product and Service Offerings

Sansheng offers a comprehensive range of hormonal solutions and technical support across different species:

• Reproductive Hormones:

  • PMSG (Pregnant Mare Serum Gonadotropin): Widely used for induction of estrus and superovulation in cattle, sheep, and goats.
  • HCG (Human Chorionic Gonadotropin): Applied in ovulation induction and fertility synchronization protocols.
  • GnRH (Gonadotropin-Releasing Hormone): Stimulates the release of LH and FSH to improve breeding outcomes.
  • Altrenogest: A progestogen used in estrus synchronization in pigs.

• Veterinary Solutions:

  • Sow Batch Farrowing Management: Hormonal protocols to standardize farrowing and improve piglet survival rates.
  • Timed Artificial Insemination (TAI): Protocols for cattle and sheep to improve breeding window accuracy.
  • Aquaculture Hormones: Induction of spawning in fish species including catfish, carp, and tilapia.

Specialization and Core USP

Sansheng’s reputation is built on its scientific rigor, product purity, and tailored protocols:

• Peptide Synthesis Expertise: Proprietary technology for large-scale synthetic peptide hormone production.
• High Purity and Bioactivity: Products maintain over 95% purity levels as validated by HPLC and Mass Spectrometry.
• Species-Specific Protocol Development: Provides custom protocols based on region, breed, and breeding cycle.
• Regulatory Compliance for Global Markets: Products meet export standards for more than 30 countries.

Financials

As a privately held company, Sansheng’s financials are not publicly disclosed. However, based on export volume and market presence:

• Estimated Annual Revenue (2022–23): $15–20 million USD
• Export Share: Approximately 80% of production is exported to Asia, Africa, Latin America, and the Middle East.
• R&D Investment: Estimated 7–9% of annual revenue dedicated to hormone synthesis and formulation development.

Shipments and Global Reach

• Export Markets: Includes Brazil, India, Nigeria, Egypt, Vietnam, and Indonesia.
• Annual Export Volume: Over 20 million I.U. of PMSG and HCG combined.
• Distribution: Through authorized veterinary distributors, importers, and government veterinary departments.

Sansheng complies with international shipping standards for cold-chain and lyophilized products, ensuring stability across geographies.

Target Market

Sansheng caters to a specialized client base across the agricultural and veterinary landscape:

• Livestock Breeding Farms
• Artificial Insemination Centers
• Veterinary Clinics and Practitioners
• Aquaculture Breeders
• Government Animal Husbandry Programs

The company also works with academic and R&D institutions conducting fertility-related trials and studies.

Capabilities

Sansheng's operational excellence is driven by advanced infrastructure and technical know-how:

• GMP-Certified Manufacturing Plant
• Automated Lyophilization Units for Hormone Preservation
• Peptide Synthesis Lab with HPLC and GC-MS Analytics
• Packaging and Serialization for Global Export Compliance
• On-Site R&D Center with Veterinary Consultants

Certifications and Compliance

Sansheng ensures global compliance through a comprehensive quality and regulatory framework:

• GMP (Good Manufacturing Practice) Certified Facility
• Veterinary Drug Manufacturing License – China
• ISO 9001:2015 Certified Quality Management System
• Products Registered in 20+ International Markets
• REACH and RoHS Compliant Materials Handling

These certifications reinforce Sansheng’s ability to supply high-quality veterinary pharmaceuticals to regulated markets.

Customer Testimonials

“Using Sansheng's PMSG has reduced our insemination failure rate significantly. Their veterinary team also provided invaluable support for synchronizing estrus cycles.”
– Livestock Farm Operator, Brazil

“For fish breeding, we rely entirely on Sansheng’s hormonal solutions. The quality and bioactivity outperform others we have tried.”
– Aquaculture Consultant, Vietnam

Major Achievements

• Exported to Over 30 Countries with high client retention and repeat orders.
• Annual Production of 10 Million I.U. of PMSG with proven efficacy rates above 95% in field trials.
• Collaborations with Veterinary Universities in China and India for hormone protocol research.
• Launch of Sansheng Aqua Division in 2022 to expand into aquaculture breeding solutions.
• Zero Product Recall Record in the last 5 years, reflecting stringent quality assurance.

Ningbo Sansheng Biological Technology Co., Ltd. continues to advance reproductive efficiency in animal husbandry through precision hormones and science-backed veterinary protocols, supporting sustainable farming and global food security.